BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 28971953)

  • 1. Rapamycin and CHIR99021 Coordinate Robust Cardiomyocyte Differentiation From Human Pluripotent Stem Cells Via Reducing p53-Dependent Apoptosis.
    Qiu XX; Liu Y; Zhang YF; Guan YN; Jia QQ; Wang C; Liang H; Li YQ; Yang HT; Qin YW; Huang S; Zhao XX; Jing Q
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mTOR Signaling Enhances Maturation of Cardiomyocytes Derived From Human-Induced Pluripotent Stem Cells via p53-Induced Quiescence.
    Garbern JC; Helman A; Sereda R; Sarikhani M; Ahmed A; Escalante GO; Ogurlu R; Kim SL; Zimmerman JF; Cho A; MacQueen L; Bezzerides VJ; Parker KK; Melton DA; Lee RT
    Circulation; 2020 Jan; 141(4):285-300. PubMed ID: 31707831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
    van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
    Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-free directed differentiation of human pluripotent stem cells efficiently produces hemogenic endothelium with lymphoid potential.
    Galat Y; Dambaeva S; Elcheva I; Khanolkar A; Beaman K; Iannaccone PM; Galat V
    Stem Cell Res Ther; 2017 Mar; 8(1):67. PubMed ID: 28302184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual modulation of the mitochondrial permeability transition pore and redox signaling synergistically promotes cardiomyocyte differentiation from pluripotent stem cells.
    Cho SW; Park JS; Heo HJ; Park SW; Song S; Kim I; Han YM; Yamashita JK; Youm JB; Han J; Koh GY
    J Am Heart Assoc; 2014 Mar; 3(2):e000693. PubMed ID: 24627421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase-3 inhibition sensitizes human induced pluripotent stem cells to thiol-containing antioxidants induced apoptosis.
    Tu C; Xu R; Koleti M; Zoldan J
    Stem Cell Res; 2017 Aug; 23():182-187. PubMed ID: 28772167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.
    Drowley L; Koonce C; Peel S; Jonebring A; Plowright AT; Kattman SJ; Andersson H; Anson B; Swanson BJ; Wang QD; Brolen G
    Stem Cells Transl Med; 2016 Feb; 5(2):164-74. PubMed ID: 26683871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-486 regulates cardiomyocyte apoptosis by p53-mediated BCL-2 associated mitochondrial apoptotic pathway.
    Sun Y; Su Q; Li L; Wang X; Lu Y; Liang J
    BMC Cardiovasc Disord; 2017 May; 17(1):119. PubMed ID: 28486954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin Promotes Cardiac Differentiation of Human Pluripotent Stem Cells in Chemically Defined Albumin-Free Medium, Enabling Consistent Manufacture of Cardiomyocytes.
    Lin Y; Linask KL; Mallon B; Johnson K; Klein M; Beers J; Xie W; Du Y; Liu C; Lai Y; Zou J; Haigney M; Yang H; Rao M; Chen G
    Stem Cells Transl Med; 2017 Feb; 6(2):527-538. PubMed ID: 28191759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the Inconsistencies of Cardiac Differentiation Efficiency Induced by the GSK3β Inhibitor CHIR99021 in Human Pluripotent Stem Cells.
    Laco F; Woo TL; Zhong Q; Szmyd R; Ting S; Khan FJ; Chai CLL; Reuveny S; Chen A; Oh S
    Stem Cell Reports; 2018 Jun; 10(6):1851-1866. PubMed ID: 29706502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte differentiation of pluripotent stem cells with SB203580 analogues correlates with Wnt pathway CK1 inhibition independent of p38 MAPK signaling.
    Laco F; Low JL; Seow J; Woo TL; Zhong Q; Seayad J; Liu Z; Wei H; Reuveny S; Elliott DA; Chai CL; Oh SK
    J Mol Cell Cardiol; 2015 Mar; 80():56-70. PubMed ID: 25528965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin Promotes Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells in a Stage-Dependent Manner.
    Jiang M; Liu T; Zhang J; Gao S; Tao B; Cao R; Qiu Y; Liu J; Li Y; Wang Y; Cao F
    Stem Cells Dev; 2020 Sep; 29(18):1229-1239. PubMed ID: 32693734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia Inhibitory Factor Increases Survival of Pluripotent Stem Cell-Derived Cardiomyocytes.
    Blüguermann C; Romorini L; Evseenko D; Garate X; Neiman G; Sevlever GE; Scassa ME; Miriuka SG
    J Cardiovasc Transl Res; 2018 Feb; 11(1):1-13. PubMed ID: 29019149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed cardiomyogenesis of human pluripotent stem cells by modulating Wnt/β-catenin and BMP signalling with small molecules.
    Aguilar JS; Begum AN; Alvarez J; Zhang XB; Hong Y; Hao J
    Biochem J; 2015 Jul; 469(2):235-41. PubMed ID: 26171831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Implication for its cardiac developmental toxicity.
    Ye D; Bao Z; Yu Y; Han Z; Yu Y; Xu Z; Ma W; Yuan Y; Zhang L; Xu Y; Ma T; Liu S; Gao X; Yan G; Huang Q; Wang X; Hua B; Yang F; Li Y; Cai B
    Toxicology; 2020 Apr; 435():152422. PubMed ID: 32112805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icariin-mediated modulation of cell cycle and p53 during cardiomyocyte differentiation in embryonic stem cells.
    Zhu D; Qu L; Zhang X; Lou Y
    Eur J Pharmacol; 2005 May; 514(2-3):99-110. PubMed ID: 15878162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of chemicals inducing cardiomyocyte proliferation in developmental stage-specific manner with pluripotent stem cells.
    Uosaki H; Magadum A; Seo K; Fukushima H; Takeuchi A; Nakagawa Y; Moyes KW; Narazaki G; Kuwahara K; Laflamme M; Matsuoka S; Nakatsuji N; Nakao K; Kwon C; Kass DA; Engel FB; Yamashita JK
    Circ Cardiovasc Genet; 2013 Dec; 6(6):624-33. PubMed ID: 24141057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling cadmium-induced cardiotoxicity using human pluripotent stem cell-derived cardiomyocytes.
    Shen J; Wang X; Zhou D; Li T; Tang L; Gong T; Su J; Liang P
    J Cell Mol Med; 2018 Sep; 22(9):4221-4235. PubMed ID: 29993192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Cardiomyocytes from Pluripotent Stem Cells.
    Nakahama H; Di Pasquale E
    Methods Mol Biol; 2016; 1353():181-90. PubMed ID: 25523811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.